News

Melanoma Risk Higher With Indoor Tanning


 

Major Finding: Overall, 63% of individuals with melanoma and 51% of controls reported any indoor tanning.

Data Source: A population-based, case-control study of 1,167 melanoma cases and 1,101 controls.

Disclosures: None of the study authors stated that they had any conflicts of interest. The study was supported in part by a grant from the American Cancer Society and the National Cancer Institute.

Indoor tanning is associated with a fourfold increased risk of melanoma, according to findings from the Skin Health Study, a population-based, case-control study of 1,167 cases and 1,101 controls.

Melanoma was 2.9 times more likely to occur in users of high-speed/high-intensity (UVB-enhanced) tanning devices and 4.4 times more likely in users of high-pressure (primarily UVA-emitting) devices, compared with individuals who had never used the devices.

In addition, melanoma was 1.8 and 1.9 times more likely in users of conventional indoor tanning devices and sunlamps, respectively, compared with never users.

The study population included individuals aged 25–59 years who were diagnosed with invasive cutaneous melanoma between July 2004 and December 2007 in Minnesota and who were enrolled in a state cancer registry. Controls were selected at random from the Minnesota state driver's license list. Study participants completed a self-administered questionnaire and a detailed 1-hour phone interview (Cancer Epidemiol. Biomarkers Prev. 2010 May 26 [doi: 10.1158/1055-9965.EPI-09-1249]).

DeAnn Lazovich, Ph.D., of the University of Minnesota, Minneapolis, and her colleagues began the Skin Health Study in 2004 in Minnesota, a state with a documented high rate of indoor tanning. Overall, 63% of individuals with melanoma and 51% of controls reported any indoor tanning. Melanoma risk increased significantly as the frequency of indoor tanning increased. Individuals with melanoma were more than twice as likely as controls to report painful burns resulting from indoor tanning, and they reported significantly more of these painful burns than controls.

The researchers also noted that a dose-response relationship between the number of tanning sessions and the number of melanoma lesions on the trunk was identified in both men and women.

“We did not find lifetime routine sun exposure or sun exposure via recreational outdoor activities or occupations to be associated with melanoma risk,” Dr. Lazovich and associates wrote. “To the extent that sunburns are a marker of intermittent sun exposure, then our results adequately represent the independent effect of indoor tanning use on the risk of melanoma.”

“As dermatologists, we see the horrible price paid for using these devices,” Dr. Allan C. Halpern, chief of dermatology at Memorial Sloan-Kettering Cancer Center, New York, said during a teleconference to discuss the study findings. Dr. Halpern was not involved in the study.

“We now know that the total amount of UV exposure in tanning beds over time is important,” Dr. Halpern said, adding that dermatologists have long understood the importance of educating patients about the dangers of indoor tanning devices, but that misinformation about the risks and benefits of indoor tanning persist.

In 2009, the International Agency for Research on Cancer classified tanning beds as carcinogenic to humans. In 2010, a Food and Drug Administration advisory panel recommended tighter restrictions on the use of indoor tanning devices, but the FDA has yet to issue any guidelines based on these recommendations.

The findings address several limitations of previous studies on this topic, including the ability to control for confounding variables such as sun exposure, the investigators noted.

Recommended Reading

Serial Screening for Melanoma Is Protective : 'We basically catch [the melanomas] before they evolve into rapidly expanding lesions.'
MDedge Internal Medicine
Digital Dermoscopy Tool Useful for Detection of Melanoma
MDedge Internal Medicine
FDA Panel Urges Restrictions on Tanning Beds
MDedge Internal Medicine
Metastasis Risk Higher With Prior SCC/BCC
MDedge Internal Medicine
Merkel Cell Virus May Be Target for Treatment
MDedge Internal Medicine
Contact Allergy to Corticosteroid Often Masked
MDedge Internal Medicine
Short Course of 3.75% Imiquimod Reduces AKs
MDedge Internal Medicine
Colchicine Cut Steroid Use in Chronic Urticaria Patients
MDedge Internal Medicine
Ustekinumab Aided Sexual Function in Psoriasis
MDedge Internal Medicine
Psoriasis Tied to Increased Risk for CV Events
MDedge Internal Medicine